Navigation Links
CryoLife Reports Record Annual Revenues of $105.1 Million for FY 2008
Date:2/19/2009

ATLANTA, Feb. 19 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE: CRY), an implantable biological medical device and tissue processing company, announced today that revenues for the year ended December 31, 2008 increased 11 percent to $105.1 million compared to $94.8 million for the year ended December 31, 2007. Excluding orthopaedic tissue processing revenues of $725,000 and $4.2 million in the years ended December 31, 2008 and December 31, 2007, respectively, total revenues increased 15 percent for the year ended 2008.

Net income for the year ended December 31, 2008 was $32.9 million, or $1.18 per basic and $1.16 per fully diluted common share, compared to $7.2 million, or $0.26 per basic and fully diluted common share for the year ended December 31, 2007. Net income for the year ended December 31, 2008 includes a tax benefit of $20.1 million, or $0.71 per fully diluted common share, related to the reversal of the Company's valuation allowance on its deferred tax assets.

Revenues for the fourth quarter of 2008 increased 2 percent to $25.5 million compared to $25.1 million for the fourth quarter of 2007. Excluding orthopaedic tissue processing revenues of $63,000 and $552,000 for the fourth quarters of 2008 and 2007, respectively, total revenues increased 4 percent for the fourth quarter of 2008.

Net income for the fourth quarter of 2008 was $22.7 million, or $0.81 per basic and $0.80 per fully diluted common share, compared to $2.6 million, or $0.10 per basic and fully diluted common share for the fourth quarter of 2007. Net income for the fourth quarter of 2008 included a tax benefit of $20.1 million, or $0.71 per fully diluted common share, related to the reversal of the Company's valuation allowance on its deferred tax assets.

Tissue processing revenues for the fourth quarter of
'/>"/>

SOURCE CryoLife, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. CryoLife Announces Release Date and Teleconference Call Details for 2008 Fourth Quarter and Year End Financial Results
2. CryoLife, Inc. Receives Tissue From 100,000th Donor, Marking Industry Milestone
3. CryoLife to Present at 20th Annual Piper Jaffray Health Care Conference
4. CryoLifes Fully Diluted Earnings Per Share Increased 71 Percent to $0.12 in Third quarter of 2008 from $0.07 in Third quarter of 2007
5. CryoLife Announces Release Date and Teleconference Call Details for Third Quarter 2008 Financial Results
6. CryoLife Hosts Worldwide Surgical Congress for the Ross Procedure
7. CryoLife Expands Distribution of Hemostase MPH(R) to Canada through Sorin Group Canada, Inc.
8. CryoLife to Present at UBS Global Life Sciences Conference
9. CryoLife Expands Distribution of Hemostase MPH(R) to France through Laboratoire Gamida
10. CryoLife Announces Management Promotions
11. CryoLifes Earnings Per Share Increased 180 Percent to $0.14 in Second Quarter of 2008 from $0.05 in Second Quarter of 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)..., , MANILA, Philippines, Dec. 2 /PRNewswire/ ...astest growing green energy companies on the plane...and True Green Planet,s President and Recycling Sp...ling business for over 25 years, stated that Spect...d is setting the stage for spectacular earnings be...
(Date:12/2/2009)..., , NEW YORK, Dec. 2 ...rch report is available in its catalogue: ,, C...ive ,, http://www.reportlinker.com/p0164368/C...ive.html ,, Incubators are the most critical ...research, and other applications for providing a c...
(Date:12/2/2009)..., , NEW YORK, Dec. 2 /PRNewswire-USNewswire...tists, policy makers, and funders today convened t...ive funding strategies at the inaugural Partnerin...shington-based center of the Milken Institute, con...ector collaborations needed to turn a scientific d...
(Date:12/2/2009)..., , TUSTIN, Calif., Dec. 2 /PRNewswire-Fi...q: PPHM ) today reported completion of patient en...l of Cotara® in patients with relapsed gliobl...in cancer. Cotara is a targeted monoclonal antibo...otential new treatment for GBM. Cotara specifical...
Breaking Biology Technology:Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5
...LOUIS, Jan. 8 Substantial progress and,momentum b...has Monsanto,(NYSE: MON ) poised to deliver sever...mpany leaders will tell investors today. The remar...on the company,s R&D pipeline in New,York and Bost...e pipeline right now," said,Steve Padgette, vice p...
...Initiative, Based on Advanced WiMAX Broadband Wire...s to Kindergartens, Elementary Schools and the ...CH TIKVA, Israel, January 8 012,Smile.Communicati... provider,of communication services in Israel, tod...stry of Communications, Intel Corporation (NYSE: ...
...SON, N.J., Jan. 7 Quest Diagnostics,Incorporated ...agnostic,testing, information and services, announ...al JPMorgan Healthcare Conference on Tuesday, Janu...isco, California. The Quest,Diagnostics presentati...e., The presentation will be webcast live during ...
Other Biology Technology:Monsanto's R&D Pipeline Set to Deliver Valuable Products to Farmers Well Into Next Decade 2Monsanto's R&D Pipeline Set to Deliver Valuable Products to Farmers Well Into Next Decade 3Israel's Ministry of Communications, 012 Smile.Communications, Intel and Alvarion Join in Launching WiMAX Initiative for Sderot, a City in the Western Negev 2Israel's Ministry of Communications, 012 Smile.Communications, Intel and Alvarion Join in Launching WiMAX Initiative for Sderot, a City in the Western Negev 3Israel's Ministry of Communications, 012 Smile.Communications, Intel and Alvarion Join in Launching WiMAX Initiative for Sderot, a City in the Western Negev 4Israel's Ministry of Communications, 012 Smile.Communications, Intel and Alvarion Join in Launching WiMAX Initiative for Sderot, a City in the Western Negev 5Quest Diagnostics to Speak at the 26th Annual JPMorgan Healthcare Conference 2
(Date:12/3/2009)...vels for the past three years in the troposphere (...area near Valladolid. The results, which are the f...that the levels rose "significantly" between 2002 ...teorologists have been trying to find out about ca...ved in the troposphere over various urban and rura...
(Date:12/3/2009)....S. Department of Energy,s (DOE) Brookhaven Nation...Institute of Science has made a major step in unde...tion in DNA that is necessary to carry out importa...n the December 1, 2009 edition of Nature Structur...ns responsible for interacting at specific sites o...
(Date:12/2/2009)...hand cigarette smoke have an increased risk of dev...er smoked. , Results of this study are publishe... , a journal of the American Association for Cance...the December issue. , This year alone, more tha...ncer; more than 159,000 will die from it and some ...
Breaking Biology News(10 mins):CO2 levels rising in troposphere over rural areas 2Grooving down the helix 2Grooving down the helix 3Secondhand smoke exposure in childhood increases lung cancer risk later in life 2Amylin Pharmaceuticals to Present at the 18th Annual Credit Suisse Healthcare Conference 6021 1Approved lymphoma drug shows promise in early tests against bone cancer 60780 1Approved lymphoma drug shows promise in early tests against bone cancer 60780 2School Violence Drops With Federal Program 60777 1School Violence Drops With Federal Program 60777 2
...ut the quality of ingested food. It comprises five...itter, and umami stimuli. The possibility for an ...ten been suggested because many animals exhibit a ... of an actual sensor remained a matter of debate. ... the Journal of Clinical Investigation, Phillipe B...
... Harvard Medical School and Massachusetts Institut...European Cancer Conference (ECCO) have shown for t...ble using nanoparticle-apatamer conjugates. , Nuc...ort DNA or RNA fragments that can bind to target a...ous to monoclonal antibodies. In the field of canc...
... microorganisms living in the oceans, but the effe...hese microbes perform for the planet remains large...American Academy of Microbiology, entitled Marine ...ty. , "Since life most likely began in the oceans,...endants of the original forms of life," says Jenni...
Other Biology News:Researchers use 'trickery' to create immune response against melanoma 2Researchers use 'trickery' to create immune response against melanoma 3Researchers use 'trickery' to create immune response against melanoma 4Understanding the oceans microbes is key to the Earth's future 2
Sheep Anti-Human Factor XIII Antibody, Horseradish Peroxidase Conjugated from CEDARLANE Laboratories Limited
Mouse Anti-RYK Monoclonal Antibody, Unconjugated, Clone F30 P7 D7 F5 from Abcam
Rabbit Anti-E2F-5 Polyclonal Antibody, Unconjugated from Spring Bioscience
LAB/Probe Mouse-Rabbit DAB Kit - 500 Tests from Biomeda Corporation
Biology Products: